Guangzhou Boji Medical and Biotechnological Co Ltd (300404) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.008x

Based on the latest financial reports, Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has a cash flow conversion efficiency ratio of -0.008x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.39 Million ≈ $-1.08 Million USD) by net assets (CN¥918.92 Million ≈ $134.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Guangzhou Boji Medical and Biotechnologi's balance sheet to measure how much of total assets are equity-financed.

Guangzhou Boji Medical and Biotechnological Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Guangzhou Boji Medical and Biotechnological Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Guangzhou Boji Medical and Biotechnologi cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Guangzhou Boji Medical and Biotechnological Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Boji Medical and Biotechnological Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pilani Investment and Industries Corporation Limited NSE:PILANIINVS	0.038x
MSC Income Fund, Inc. NYSE:MSIF	0.019x
Shenzhen Bestek Technology Co Ltd SHE:300822	0.014x
Delpha Construction Co Ltd TW:2530	-0.071x
Beijing Tieke Shougang Railway Tech Co Ltd SHG:688569	0.065x
Actblue Co Ltd SHE:300816	0.054x
Arvinas Inc NASDAQ:ARVN	-0.070x
YLZ Information Tech Co SHE:300096	-0.049x

Annual Cash Flow Conversion Efficiency for Guangzhou Boji Medical and Biotechnological Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Guangzhou Boji Medical and Biotechnologi stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.06 Billion ≈ $155.04 Million	CN¥87.01 Million ≈ $12.73 Million	0.082x	+207.18%
2024-12-31	CN¥1.00 Billion ≈ $146.59 Million	CN¥26.78 Million ≈ $3.92 Million	0.027x	-27.12%
2023-12-31	CN¥980.11 Million ≈ $143.42 Million	CN¥35.95 Million ≈ $5.26 Million	0.037x	+15.86%
2022-12-31	CN¥888.72 Million ≈ $130.05 Million	CN¥28.14 Million ≈ $4.12 Million	0.032x	-10.97%
2021-12-31	CN¥846.38 Million ≈ $123.85 Million	CN¥30.10 Million ≈ $4.40 Million	0.036x	-82.23%
2020-12-31	CN¥485.00 Million ≈ $70.97 Million	CN¥97.07 Million ≈ $14.20 Million	0.200x	+106199.25%
2019-12-31	CN¥456.08 Million ≈ $66.74 Million	CN¥85.87K ≈ $12.57K	0.000x	-99.71%
2018-12-31	CN¥423.71 Million ≈ $62.00 Million	CN¥27.06 Million ≈ $3.96 Million	0.064x	+0.92%
2017-12-31	CN¥414.35 Million ≈ $60.63 Million	CN¥26.22 Million ≈ $3.84 Million	0.063x	+179.45%
2016-12-31	CN¥429.84 Million ≈ $62.90 Million	CN¥-34.24 Million ≈ $-5.01 Million	-0.080x	-1889.41%
2015-12-31	CN¥432.68 Million ≈ $63.32 Million	CN¥1.93 Million ≈ $281.83K	0.004x	-96.21%
2014-12-31	CN¥218.48 Million ≈ $31.97 Million	CN¥25.69 Million ≈ $3.76 Million	0.118x	-44.43%
2013-12-31	CN¥205.52 Million ≈ $30.07 Million	CN¥43.48 Million ≈ $6.36 Million	0.212x	-12.94%
2012-12-31	CN¥170.36 Million ≈ $24.93 Million	CN¥41.40 Million ≈ $6.06 Million	0.243x	--

About Guangzhou Boji Medical and Biotechnological Co Ltd

SHE:300404 China Biotechnology

Market Cap

$520.44 Million

CN¥3.56 Billion CNY

Market Cap Rank

#11875 Global

#3366 in China

Share Price

CN¥9.22

Change (1 day)

+0.77%

52-Week Range

CN¥8.29 - CN¥13.15

All Time High

CN¥297.35